Breaking News Instant updates and real-time market news.

INCY

Incyte

$88.17

0.14 (0.16%)

15:02
02/15/18
02/15
15:02
02/15/18
15:02

Incyte risk/reward is favorable, says BMO Capital

  • 15

    Feb

INCY Incyte
$88.17

0.14 (0.16%)

01/12/18
STFL
01/12/18
NO CHANGE
Target $27
STFL
Buy
Concert pullback on PTAB decision a buying opportunity, says Stifel
Stifel analyst Adam Walsh called the news that the USPTO denied Concert Pharmaceuticals' Post Grant Review petition on Incyte's (INCY) '335 patent for Jakafi a "setback," but "certainly not the end" for Concert's deuterated ruxolitinib for alopecia areata. The PTAB decision does not prohibit Concert from challenging the '335 patent's validity at a later time in court, noted Walsh, who also points out the Phase 2a trial in alopecia areata will continue as planned. The analyst, who sees today's pullback as a buying opportunity, keeps a Buy rating on Concert shares but lowered his price target on the stock to $27 from $30.
01/12/18
01/12/18
DOWNGRADE
Target $23

Neutral
Concert Pharmaceuticals downgraded on valuation, litigation overhang at Mizuho
As previously reported, Mizuho analyst Difei Yang downgraded Concert Pharmaceuticals (CNCE) to Neutral from Buy, calling the stock fairly valued at current levels. Additionally, while Yang does not believe the Patent Trial and Appeal Board decision to deny a Post Grant Review in the company's ongoing dispute with Incyte (INCY) has any implications for the ultimate outcome of Concert's trial, the decision does leave a litigation overhang on the stock. Also, two phase 3 trial readouts for AVP-786 were pushed out to 2019, leaving Concert with one less potential catalyst in 2018, said Yang, who keeps a $23 price target on the stock.
01/16/18
MZHO
01/16/18
DOWNGRADE
Target $23
MZHO
Neutral
Concert Pharmaceuticals downgraded to Neutral from Buy at Mizuho
Mizuho downgraded Concert Pharmaceuticals (CNCE) to Neutral with a $23 price target after the Patent Trial and Appeal Board did not grant the company a Post Grant Review in the ongoing Patent '355 dispute with Incyte Pharma (INCY). While the firm believes this development has no implications for the ultimate outcome of the trial, it does mean the litigation overhang will remain in the foreseeable future. Further, Mizuho sees the stock as fairly valued.
01/22/18
OPCO
01/22/18
NO CHANGE
Target $110
OPCO
Perform
Incyte price target lowered to $110 from $120 at Oppenheimer
Oppenheimer analyst Jay Olson lowered his price target for Incyte to $110 from $120 as he now sees a higher hurdle in NSCLC for epa and consequently lower probability of success than previously. The analyst reiterates a Perform rating on the shares.

TODAY'S FREE FLY STORIES

FB

Facebook

$145.70

0.63 (0.43%)

, SNAP

Snap

$5.92

0.035 (0.60%)

13:11
12/14/18
12/14
13:11
12/14/18
13:11
On The Fly
#SocialStocks: Facebook's photo bug, Snap hires new Communications Chief »

Welcome to…

FB

Facebook

$145.70

0.63 (0.43%)

SNAP

Snap

$5.92

0.035 (0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:08
12/14/18
12/14
13:08
12/14/18
13:08
General news
Baker-Hughes Rig Count N. Amer. data reported »

Week of 12/14…

COG

Cabot Oil & Gas

$23.38

-0.73 (-3.03%)

13:05
12/14/18
12/14
13:05
12/14/18
13:05
Options
Cabot Oil & Gas call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

BHGE

Baker Hughes

$21.66

-0.38 (-1.72%)

13:03
12/14/18
12/14
13:03
12/14/18
13:03
Hot Stocks
Baker Hughes reports U.S. rig count down 4 to 1,071 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

JNJ

Johnson & Johnson

$134.33

-13.475 (-9.12%)

12:56
12/14/18
12/14
12:56
12/14/18
12:56
Periodicals
Breaking Periodicals news story on Johnson & Johnson »

Johnson & Johnson to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MO

Altria Group

$52.80

-1.11 (-2.06%)

12:55
12/14/18
12/14
12:55
12/14/18
12:55
Options
Altria Group put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$187.13

-0.08 (-0.04%)

, UPS

UPS

$98.70

-2.07 (-2.05%)

12:55
12/14/18
12/14
12:55
12/14/18
12:55
Conference/Events
UBS services analyst to hold an analyst/industry conference call »

Services Analyst Wadewitz…

FDX

FedEx

$187.13

-0.08 (-0.04%)

UPS

UPS

$98.70

-2.07 (-2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

12:47
12/14/18
12/14
12:47
12/14/18
12:47
Conference/Events
CFTC to hold a podcast on 2018 and 2019 »

Daniel Gorfine, the…

D

Dominion

$76.38

0.35 (0.46%)

12:46
12/14/18
12/14
12:46
12/14/18
12:46
Hot Stocks
Dominion board increases 2019 dividend 10% to $3.67 per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KORS

Michael Kors

$38.09

0.6 (1.60%)

12:45
12/14/18
12/14
12:45
12/14/18
12:45
Options
Michael Kors call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
12/14/18
12/14
12:45
12/14/18
12:45
General news
U.S. equities remain upwardly challenged »

U.S. equities remain…

12:45
12/14/18
12/14
12:45
12/14/18
12:45
General news
Breaking General news story  »

Week of 12/14…

VLKAY

Volkswagen

$0.00

(0.00%)

, F

Ford

$8.60

0.095 (1.12%)

12:43
12/14/18
12/14
12:43
12/14/18
12:43
Periodicals
VW, Ford cooperation talks moving forward, Reuters says »

Volkswagen's (VLKAY)…

VLKAY

Volkswagen

$0.00

(0.00%)

F

Ford

$8.60

0.095 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

PNC

PNC Financial

$119.66

-0.25 (-0.21%)

12:43
12/14/18
12/14
12:43
12/14/18
12:43
Syndicate
Breaking Syndicate news story on PNC Financial »

PNC Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

  • 12

    Apr

  • 17

    Jul

  • 16

    Oct

TRGP

Targa Resources

$42.36

-1.88 (-4.25%)

12:35
12/14/18
12/14
12:35
12/14/18
12:35
Options
Targa Resources put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$133.15

-14.65 (-9.91%)

12:34
12/14/18
12/14
12:34
12/14/18
12:34
Recommendations
Johnson & Johnson analyst commentary  »

BMO Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$133.37

-14.43 (-9.76%)

12:31
12/14/18
12/14
12:31
12/14/18
12:31
Recommendations
Johnson & Johnson analyst commentary  »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHK

Chesapeake

$2.39

-0.19 (-7.36%)

12:20
12/14/18
12/14
12:20
12/14/18
12:20
Options
Ratio put spread in Chesapeake as shares drop 7.3% and fall to 52-week lows »

Ratio put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/14/18
12/14
12:17
12/14/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/14/18
12/14
12:16
12/14/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$133.26

-14.54 (-9.84%)

, SBUX

Starbucks

$64.61

-2.29 (-3.42%)

12:15
12/14/18
12/14
12:15
12/14/18
12:15
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened lower…

JNJ

Johnson & Johnson

$133.26

-14.54 (-9.84%)

SBUX

Starbucks

$64.61

-2.29 (-3.42%)

ADBE

Adobe

$233.37

-14.34 (-5.79%)

COST

Costco

$207.71

-18.7 (-8.26%)

BEL

Belmond

$24.67

7 (39.62%)

LVMUY

LVMH

$0.00

(0.00%)

KANG

iKang Healthcare

$20.30

2.03 (11.11%)

IDRA

Idera Pharmaceuticals

$5.34

-1.26 (-19.09%)

CDE

Coeur Mining

$3.89

-0.165 (-4.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

PFE

Pfizer

$43.45

-1.105 (-2.48%)

12:14
12/14/18
12/14
12:14
12/14/18
12:14
Hot Stocks
Pfizer announces new $10B share repurchase program »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PFE

Pfizer

$43.52

-1.03 (-2.31%)

12:13
12/14/18
12/14
12:13
12/14/18
12:13
Hot Stocks
Pfizer raises quarterly dividend 6% to 36c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PFE

Pfizer

$43.52

-1.03 (-2.31%)

12:12
12/14/18
12/14
12:12
12/14/18
12:12
Hot Stocks
Breaking Hot Stocks news story on Pfizer »

Pfizer boosts dividend to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

ECA

Encana

$5.93

-0.295 (-4.74%)

12:10
12/14/18
12/14
12:10
12/14/18
12:10
Options
Call buyers in Encana as shares suffer additional losses »

Call buyers in Encana as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.